Menu Back to Latin-America-Annual-Meeting

Overview

Meeting:
Day One: March 6 – 10:00AM-3:00PM
Day Two: March 7 – 10:00AM-3:00PM
Day Three: March 8 - 10:00AM-3:00PM

DIA is thrilled to announce our 2023 Latin America Annual Meeting that will include opportunities for networking and knowledge sharing with key stakeholders influencing the advancement and implementation of initiatives in Latin America and the Caribbean. This new meeting expands in scope from our previous meetings discussing topics relating to the Latin America region, and presents the following three tracks: Regulatory, Clinical and Pharmacovigilance. Cross-track sessions provide the opportunity to discuss key connection points across major components of regulatory, clinical and pharmacovigilance initiatives, efforts and collaboration within these functional areas in an organization or company. Join us to discuss multi-regional cooperation, global harmonization, lessons learned, and best practices to stimulate discussion and foster collaboration amongst stakeholders in Latin America and the Caribbean.

Registered attendees will receive access to all session recordings for 2 full months post-conference! This allows you to remain flexible with your schedule and not worry if you need to miss a session. Have a conflict with the dates of the conference? Register anyway and you will receive access to the recordings!

  • Meeting Designed For:

    • Academia
    • Benefit-Risk Assessment and Communication
    • Clinical Research and Development
    • Clinical Operations
    • CROs/Vendors
    • Drug Regulation
    • Drug Safety/Pharmacovigilance
    • Global Submission/Project Management
    • Government Affairs
    • Manufacturing
    • Medical and Scientific Affairs
    • Medical Communication
    • Medical Information
    • Medical Product Safety Assessment
    • Pharmacoepidemiology
    • Policy and Intelligence
    • Post-Market Studies
    • Quality Assurance and Compliance
    • Real-World Evidence
    • Regulatory Agencies
    • Regulatory Affairs, Operations, and Strategy
    • Research and Development
    • Risk Management, including Risk Evaluation and Mitigation Strategies (REMS)
    • Strategic Sourcing/Planning

Program Committee

  • Fernanda  Lessa, MBA, MPH
    Fernanda Lessa, MBA, MPH
    N/A, Switzerland
  • Viktoria  Magyar, LLM, MSc
    Viktoria Magyar, LLM, MSc Student
    USC School of Pharmacy, United States
  • Maria Antonieta Tony Roman, MPharm
    Maria Antonieta Tony Roman, MPharm Head Regulatory Policy Emerging Markets LATAM
    Novartis, Mexico
  • Leonardo  Semprun, RPh
    Leonardo Semprun, RPh Senior Director, Global Regulatory Policy LATAM
    MSD, Panama
  • Urimara  Argotti-Rodriguez, MBA
    Urimara Argotti-Rodriguez, MBA Regional Regulatory Policy LATAM Region, Global International Regulatory Policy
    Productos Roche S.A. DE C.V., Mexico
  • Flavia  Firmino Ribeiro
    Flavia Firmino Ribeiro Director Reg Global CMC
    Pfizer, Brazil
  • Gislaine  Dib, PharmD
    Gislaine Dib, PharmD Pharmacovigilance Coordinator
    Libbs Farmacêutica, Brazil
  • Raphael Elmadjian Pareschi, MBA
    Raphael Elmadjian Pareschi, MBA Associate Director/ Pharmacovigilance Brazil
    MSD, Brazil
  • Rosana Miguel Messias Mastellaro, PharmD, RPh
    Rosana Miguel Messias Mastellaro, PharmD, RPh Director of Regulatory Affairs
    Sindusfarma, Brazil
  • Deirdre  McCarthy, MSc
    Deirdre McCarthy, MSc Senior Director, Pharmacovigilance and Safety Operations
    Allovir, United States
  • Bianca  Passos, PharmD, MBA
    Bianca Passos, PharmD, MBA Country Safety Head - Brazil
    Sanofi, Brazil
  • Michelle  Rocha de Souza, MBA
    Michelle Rocha de Souza, MBA Pharmacovigilance Coordinator
    Abbvie, Brazil
  • Michelle  Arguelles Gonzalez, RPh
    Michelle Arguelles Gonzalez, RPh Regional Operations Head
    Merck, S.A. De C.V., Mexico
  • Duglas  Rodriguez Calderon
    Duglas Rodriguez Calderon Head of LATAM Regulatory Policy, Global Regulatory Policy & Intelligence
    Roche, Panama
  • Lorena  Larrosa
    Lorena Larrosa Regulatory Affairs Manager
    Abbvie, Uruguay
  • Susan  Koepke, MBA
    Susan Koepke, MBA Head of Regulatory Affairs LATAM
    EMD Serono, Inc., United States
  • Ana Patricia  Pineda, MSc
    Ana Patricia Pineda, MSc International Regulatory Analyst, OIP, OGROP, OC
    US FDA, Mexico
Load More